These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15775755)

  • 1. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment.
    Mouchawar J; Hensley-Alford S; Laurion S; Ellis J; Kulchak-Rahm A; Finucane ML; Meenan R; Axell L; Pollack R; Ritzwoller D
    Genet Med; 2005 Mar; 7(3):191-7. PubMed ID: 15775755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization.
    Mouchawar J; Laurion S; Ritzwoller DP; Ellis J; Kulchak-Rahm A; Hensley-Alford S
    Am J Manag Care; 2005 Oct; 11(10):601-8. PubMed ID: 16232001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Be ready against cancer, now": direct-to-consumer advertising for genetic testing.
    William-Jones B
    New Genet Soc; 2006 Apr; 25(1):89-107. PubMed ID: 17312631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct to confusion: lessons learned from marketing BRCA testing.
    Matloff E; Caplan A
    Am J Bioeth; 2008 Jun; 8(6):5-8. PubMed ID: 18726769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: "Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally occurring experiment".
    Williams MS
    Genet Med; 2005 Sep; 7(7):514; author reply 514. PubMed ID: 16170245
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk.
    Lowery JT; Byers T; Axell L; Ku L; Jacobellis J
    Genet Med; 2008 Dec; 10(12):888-94. PubMed ID: 19092441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic influences on the effects of a genetic testing direct-to-consumer marketing campaign.
    Bowen DJ; Harris J; Jorgensen CM; Myers MF; Kuniyuki A
    Public Health Genomics; 2010; 13(3):131-42. PubMed ID: 19641293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.
    Hull SC; Prasad K
    Reprod Health Matters; 2001 Nov; 9(18):44-8. PubMed ID: 11765398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest in BRCA1/2 testing in a primary care population.
    Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
    Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
    Aitken L; Warwick L; Davis A
    Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/2 genetic testing in the community setting.
    Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
    J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-consumer marketing of genetic tests for cancer: buyer beware.
    Gray S; Olopade OI
    J Clin Oncol; 2003 Sep; 21(17):3191-3. PubMed ID: 12874271
    [No Abstract]   [Full Text] [Related]  

  • 17. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.
    Kolor K; Chen Z; Grosse SD; Rodriguez JL; Green RF; Dotson WD; Bowen MS; Lynch JA; Khoury MJ
    MMWR Surveill Summ; 2017 Sep; 66(15):1-11. PubMed ID: 28880857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of BRCA1/2 mutation testing among young survivors of breast cancer.
    Kehl KL; Shen C; Litton JK; Arun B; Giordano SH
    Breast Cancer Res Treat; 2016 Jan; 155(1):165-73. PubMed ID: 26706041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.